retatrutide phase 2 trial type 2 diabetes triple agonist glp-1 gip glucagon obesity Retatrutide, a GIP, and receptor Retatrutide Blood Sugar Results: 2.02%
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




























